Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

Alessandro Armuzzi, Antonio Gasbarrini, Luisa Guidi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

45 Citazioni (Scopus)

Abstract

Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen.
Lingua originaleEnglish
pagine (da-a)852-858
Numero di pagine7
RivistaJournal of Crohn's and Colitis
Volume8
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • Colectomy
  • Infliximab
  • Ulcerative colitis

Fingerprint

Entra nei temi di ricerca di 'Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy'. Insieme formano una fingerprint unica.

Cita questo